Coronavirus Update: Pfizer, BioNTech Hit Ground Running On Vaccine EUA

US FDA will hold 10 December advisory committee on Pfizer/BioNTech's just-filed application; the WHO issued a recommendation against Gilead's Veklury for hospitalized patients.

COVID-19 vaccine
• Source: Shutterstock

The vaccine against SARS-CoV-2 developed by Pfizer Inc. and BioNTech SE could become available for high-risk populations toward the end of this year if the companies are able to secure an emergency use authorization from the US Food and Drug Administration.

The US-based drug maker and German biotech submitted a request to the FDA on 20 November seeking an EUA for...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip